Zimmer Biomet Holdings Inc logo

ZBH - Zimmer Biomet Holdings Inc Share Price

$128.34 1.6  1.3%

Last Trade - 27/05/20

Sector
Healthcare
Size
Large Cap
Market Cap £21.26bn
Enterprise Value £27.13bn
Revenue £6.32bn
Position in Universe 325th / 6359
Bullish
Bearish
Unlock ZBH Revenue
Momentum
Relative Strength (%)
1m
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Margin of Safety
Qualifying GuruScreens
Financial Summary
FINANCIAL BRIEF: : For the three months ended 31 March 2020, Zimmer Biomet Holdings Inc revenues decreased 10% to $1.78B. Net loss totaled $508.5M vs. income of $246.1M. Revenues reflect Americas segment decrease of 8% to $1.1B, EMEA segment decrease of 14% to $398.1M. Net loss reflects Selling, general and administrative increase of 4% to $828.9M (expense), Foreign exchange forward contracts increase from $7.2M to $15.6M (expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

ZBH Revenue Unlock ZBH Revenue

Net Income

ZBH Net Income Unlock ZBH Revenue

Normalised EPS

ZBH Normalised EPS Unlock ZBH Revenue

PE Ratio Range

ZBH PE Ratio Range Unlock ZBH Revenue

Dividend Yield Range

ZBH Dividend Yield Range Unlock ZBH Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
ZBH EPS Forecasts Unlock ZBH Revenue
Profile Summary

Zimmer Biomet Holdings, Inc. is engaged in designing, manufacturing and marketing of orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; office-based technologies; spine, craniomaxillofacial and thoracic products; dental implants, and related surgical products. The Company's products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues. The Company manages its operations through three geographic operating segments: the Americas, consisting principally of the United States and other North, Central and South American markets; EMEA, consisting principally of Europe and the Middle East and African markets, and Asia Pacific, consisting primarily of Japan and other Asian and Pacific markets. The Company's product category segments include Americas Spine, Office Based Technologies, Craniomaxillofacial and Thoracic (CMF), and Dental.

Directors
Last Annual December 31st, 2019
Last Interim March 31st, 2020
Incorporated January 12, 2001
Public Since July 25, 2001
No. of Shareholders: 17,900
No. of Employees: 19,900
Sector Healthcare
Industry Healthcare Equipment & Supplies
Index S&P Composite 1500 , S&P 500 , S&P 500 Health Care (sector),
Exchange New York Stock Exchange
Shares in Issue 206,802,113
Free Float (0.0%)
Eligible for
ISAs
SIPPs
ZBH Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for ZBH
Upcoming Events for ZBH
Friday 24th July, 2020 Estimate
Q2 2020 Zimmer Biomet Holdings Inc Earnings Release
Tuesday 3rd November, 2020 Estimate
Q3 2020 Zimmer Biomet Holdings Inc Earnings Release
Frequently Asked Questions for Zimmer Biomet Holdings Inc
What is the Zimmer Biomet Holdings Inc share price?

As of 27/05/20, shares in Zimmer Biomet Holdings Inc are trading at $128.34, giving the company a market capitalisation of £21.26bn. This share price information is delayed by 15 minutes.

How has the Zimmer Biomet Holdings Inc share price performed this year?

Shares in Zimmer Biomet Holdings Inc are currently trading at $128.34 and the price has moved by 10.67% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Zimmer Biomet Holdings Inc price has moved by 4.94% over the past year.

What are the analyst and broker recommendations for Zimmer Biomet Holdings Inc?

Of the analysts with advisory recommendations for Zimmer Biomet Holdings Inc, there are there are currently 13 "buy" , 7 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Zimmer Biomet Holdings Inc is Buy. You can view the full broker recommendation list by unlocking its StockReport.

When will Zimmer Biomet Holdings Inc next release its financial results?

Zimmer Biomet Holdings Inc is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-03-31
What is the Zimmer Biomet Holdings Inc dividend yield?

The Zimmer Biomet Holdings Inc dividend yield is 0.76% based on the trailing twelve month period.

Does Zimmer Biomet Holdings Inc pay a dividend?

Last year, Zimmer Biomet Holdings Inc paid a total dividend of 0.96, and it currently has a trailing dividend yield of 0.76%. Looking ahead, Zimmer Biomet Holdings Inc has not announced an ex-dividend date yet.

When does Zimmer Biomet Holdings Inc next pay dividends?

Zimmer Biomet Holdings Inc has yet to annouce their ex-dividend date. The historic dividend yield on Zimmer Biomet Holdings Inc shares is currently 0.76%.

How do I buy Zimmer Biomet Holdings Inc shares?

To buy shares in Zimmer Biomet Holdings Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Zimmer Biomet Holdings Inc?

Shares in Zimmer Biomet Holdings Inc are currently trading at $128.34, giving the company a market capitalisation of £21.26bn.

Where are Zimmer Biomet Holdings Inc shares listed? Where are Zimmer Biomet Holdings Inc shares listed?

Here are the trading details for Zimmer Biomet Holdings Inc:

Country of listing: United States
Exchange: NYQ
Ticker Symbol: ZBH
What kind of share is Zimmer Biomet Holdings Inc?

Based on an overall assessment of its quality, value and momentum, Zimmer Biomet Holdings Inc is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Zimmer Biomet Holdings Inc share price forecast 2020?

Shares in Zimmer Biomet Holdings Inc are currently priced at $128.34. At that level they are trading at 15.1% discount to the analyst consensus target price of 0.00.

Analysts covering Zimmer Biomet Holdings Inc currently have a consensus Earnings Per Share (EPS) forecast of 6.135 for the next financial year.

How can I tell whether the Zimmer Biomet Holdings Inc share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Zimmer Biomet Holdings Inc. Over the past six months, the relative strength of its shares against the market has been -8.09%. At the current price of $128.34, shares in Zimmer Biomet Holdings Inc are trading at -5.25% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Zimmer Biomet Holdings Inc PE Ratio?

The Zimmer Biomet Holdings Inc PE ratio based on its reported earnings over the past 12 months is 17.76. The shares are currently trading at $128.34.

The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.

The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.

Who are the key directors of Zimmer Biomet Holdings Inc?

Zimmer Biomet Holdings Inc's management team is headed by:

Bryan Hanson - PRE
Chad Phipps - SVP
Sang Yi - CEX
Ivan Tornos - CEX
Betsy Bernard - IND
Larry Glasscock - NEC
Christopher Begley - IND
Gail Boudreaux - IND
Michael Farrell - IND
Suketu Upadhyay - CFO
Carrie Nichol - CAO
Keri Mattox - SVP
Didier Deltort - CEX
Who are the major shareholders of Zimmer Biomet Holdings Inc?

Here are the top five shareholders of Zimmer Biomet Holdings Inc based on the size of their shareholding:

The Vanguard Group, Inc. Investment Advisor/Hedge Fund
Percentage owned: 7.88% (16.3m shares)
BlackRock Institutional Trust Company, N.A. Investment Advisor
Percentage owned: 5.3% (11.0m shares)
MFS Investment Management Investment Advisor/Hedge Fund
Percentage owned: 4.96% (10.3m shares)
State Street Global Advisors (US) Investment Advisor/Hedge Fund
Percentage owned: 4.13% (8.54m shares)
Capital Research Global Investors Investment Advisor
Percentage owned: 3.79% (7.84m shares)
Similar to ZBH
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.